Lauren Nye

5PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 07, 2025
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.

Qamar J Khan, Colleen Bohnenkamp, Taylor E Monson

|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.

Miguel Martín, Rachel Yoder, Roberto Salgado

|Feb 11, 2023
Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy.

Sean C Liebscher, Lyndsey J Kilgore, Onalisa Winblad

|Dec 01, 2022
Everolimus for Estrogen Receptor-negative Breast Cancer Prevention: A Journey Begun?

Lauren Nye, Seema A Khan

|Feb 19, 2021
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.

Priyanka Sharma, Vandana G Abramson, Anne O'Dea

Pageof 1